J

Jenburkt Pharmaceuticals Limited

JENBURPH
Market snapshot · 2026-08-11 16:05 UTC

1,065.10

+₹2.40 (+0.23%)

MARKET CAP

₹470.06 Cr

STOCK P/E

13.5x

52W HIGH

₹1,321.00

52W LOW

₹944.00

BOOK VALUE

₹446.40

EPS

₹78.75

ROE

18.84%

SECTOR

Health Care

DEBT/EQUITY

1.26

VOLUME

2,097

P/B RATIO

2.39x

PEG RATIO

0.50

Sector

Health Care

Themes

Pharmaceuticals
₹1,272.90₹1,204.75₹1,136.60₹1,068.45₹1,000.30VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 2.8% above historical median. Valuation is stable — currently in the overvalued zone (z-score: +0.41). Confidence: 80%.

Live forward EPS implies next-12-month EPS of ₹34.86. Applying the stock's normalized valuation corridor produces a fair range of ₹361.50 to ₹501.64, with base value near ₹460.50 (-56.9% vs current price).

Forward Valuation Outlook

Live forward estimate anchored to the company's historical valuation corridor.

Above normalized range

Forward EPS

₹34.86

Forward P/E

30.7x

Base Fair Value

₹460.50

Fair Range

₹361.50 - ₹501.64

Upside To Base

-56.9%

Estimate Source

Live forward EPS

Growth Estimate

+27.1%

P/E
Overvalued

5Y Average

10.47

Current

13.58

Overvalued

14.39

Undervalued

10.37

EV/EBITDA
Strongly Overvalued

5Y Average

7.31

Current

9.48

Overvalued

9.52

Undervalued

5.38

P/S
Strongly Overvalued

5Y Average

2.16

Current

2.80

Overvalued

2.48

Undervalued

1.83

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹36 CrJun 2026

Latest net profit

₹5.89 CrJun 2026

Latest EPS

₹13.35Jun 2026

Net margin

17.0%Jun 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.0%8.0%16.0%24.0%32.0%0.00 Cr15 Cr30 Cr45 Cr60 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.00 Cr15 Cr30 Cr45 Cr60 Cr₹0₹7₹14₹21₹28
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr9.00 Cr18 Cr27 Cr36 Cr

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 20260.00 Cr60 Cr120 Cr180 Cr240 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales +29.1838.2935.6638.8432.5441.2236.8941.0535.5345.5643.0244.6335.51
Expenses +22.2229.1928.4728.9923.2629.7928.0730.1926.5832.4535.5930.3829.48
Operating Profit6.969.107.199.859.2811.438.8210.868.9513.117.4314.256.03
OPM %23.85%23.77%20.16%25.36%28.52%27.73%23.91%26.46%25.19%28.78%17.27%31.93%16.98%
Other Income +1.041.101.351.191.411.851.581.882.062.081.820.401.51
Interest0.070.070.070.060.110.120.110.110.110.110.120.130.13
Depreciation0.500.590.630.620.520.640.780.790.720.740.830.810.64
Profit before tax7.439.547.8410.3610.0612.529.5111.8410.1814.348.3013.716.77
Tax %27.73%23.27%31.12%23.94%26.34%23.32%31.65%27.87%23.48%29.08%28.55%20.86%13.00%
Net Profit +5.377.325.407.887.429.606.518.547.7910.165.9310.855.89
EPS in Rs12.1716.5912.2417.8616.8121.7514.7519.3517.6523.0213.4424.5813.35
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +46.67%46.66%46.65%46.64%46.62%
DIIs +0.12%0.12%0.12%0.12%0.12%
Public +53.21%53.22%53.24%53.24%53.27%
Jun 2026
Promoters +
DIIs +
Public +

Events Timeline

Annual Report FY26

FY2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

Aug 07, 2026PDFCompany Reports Open

Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.

Aug 06, 2026PDFCompany Reports Open

Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 06Th August, 2026.

Aug 06, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

Aug 04, 2026PDFCompany Reports Open